Last updated on January 2019

A Pragmatic Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients (DECIDE Study)


Brief description of study

A trial of patients with type 2 diabetes mellitus to evaluate the comparative effectiveness between dapagliflozin and Standard of Care (SOC)

Detailed Study Description

A longitudinal, open labelled, pragmatic randomized 104 week multicentre trial of patients with type 2 diabetes mellitus to evaluate the comparative effectiveness between dapagliflozin and Standard of Care (SOC)

Clinical Study Identifier: NCT02616666

Find a site near you

Start Over

Research Site

Surrey, United Kingdom
  Connect »

Research Site

Guildford, United Kingdom
5.45miles
  Connect »

Research Site

Camberley, United Kingdom
8.02miles
  Connect »

Research Site

Farnborough, United Kingdom
8.54miles
  Connect »